CLCaroline Lilliecreutz

Caroline Lilliecreutz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caroline Lilliecreutz has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Maternal and neonatal outcomes in a reduced visit antenatal care program for women at low risk for complications

    by Valerie Stålberg, Marie Bladh, Barbro Krevers, Louise Möller, Nina Lindell, Ann Josefsson, Caroline Lilliecreutz

  • Open Access

    Prediction of term preeclampsia using angiogenic biomarkers at 24–29 weeks gestation

    by Stina Björkman, Marie Bladh, Sara Bergstrand, Sofia Sederholm Lawesson, Elisabeth Aardal, Martin Overgaard, Caroline Lilliecreutz


  • Open Access

    Pregestational Diabetes and Duration of Active Labour Compared With Non‐Diabetic Women: A Population‐Based Cohort Study

    by Sofia Nevander, Sara Carlhäll, Karin Källén, Caroline Lilliecreutz, Marie Blomberg

    Objective: To evaluate the impact of pregestational diabetes on duration of active labour (DAL) in induced and spontaneous labour and to compare caesarean section (CS) rates and indications between women with and without diabetes. Design: A population‐based cohort study. Setting: Sweden. Population: 243 537 nulliparous women, registered in the Swedish Pregnancy Register, who delivered a singleton fetus at ≥ 34 +0 gestational weeks + days between 2014 and 2020. Women with gestational diabetes mellitus were excluded. Methods: DAL was compared between women with pregestational diabetes and those without diabetes using Kaplan‐Meier survival analysis and Cox regression analysis. Main Outcome Measures: DAL. Rates and indications for CS. Results: Women with pregestational diabetes had longer active labour and a reduced chance of vaginal delivery at a given time‐point compared to women without diabetes, adjusted hazard ratio 0.65 (95% CI: 0.60–0.70, p < 0.001). Among those with spontaneous labour, median DAL in diabetic vs. non‐diabetic women was 9.60 h versus 8.75 h, difference 0.85 h (95% CI 0.20–1.50), p < 0.001. Corresponding numbers for induced labours were 8.92 h versus 7.20 h, difference 1.72 h (95% CI 0.94–2.49), p < 0.001. Elective and emergency CS rates were higher in women with pregestational diabetes than non‐diabetic women (7.4% and 29.4% vs. 2.6% and 7.1% respectively), with suspected macrosomia (50.4%) and fetal distress (31.9%) being the most common indications for CS among women with pregestational diabetes. Conclusions: The prolonged labour duration in women with pregestational diabetes highlights the importance of the labour ward staff's support and patience in managing diabetic parturients, potentially allowing more time before diagnosing labour dystocia. Extended labour duration may also influence women's birth experience.


  • Open Access

    Gestational diabetes mellitus and time in active labor: A population‐based cohort study

    by Sofia Nevander, Sara Carlhäll, Karin Källén, Caroline Lilliecreutz, Marie Blomberg

    Introduction: Women with gestational diabetes mellitus (GDM) have higher rates of adverse perinatal outcomes compared with women without GDM, including an increased risk for having labor induced and for cesarean section. The findings from previous studies analyzing duration of labor in women with GDM are contradictory.The aim of the study was to evaluate the impact of GDM on time in spontaneous and induced active labor.Material and methods: This was a population‐based cohort study including 247 524 primiparous women who gave birth to a singleton fetus with cephalic presentation, ≥34+0 (completed gestational weeks + additional days) between January 2014 and May 2020 in Sweden. Data was obtained from the Swedish Pregnancy Register. Time in active labor was compared between women with GDM and without GDM with a spontaneous labor onset or induction of labor using Kaplan Meier survival analysis and Cox regression analysis.Results: Women with GDM had significantly longer time in active labor, both with a spontaneous onset and induction of labor compared to women without GDM. Women with GDM had a decreased chance of vaginal delivery at a certain time‐point compared to women without GDM, with adjusted hazard ratio of 0.92 (0.88–0.96) and 0.83 (0.76–0.90) for those with spontaneous onset and induction of labor, respectively. Women with GDM had increased risk for time in active labor ≥12 h both in spontaneous labor onset (adjusted odds ratio 1.14 [1.04–1.25]) and in induction of labor (adjusted odds ratio 1.55 [1.28–1.87]).Conclusions: Women with GDM seem to spend a longer time in active labor, both in spontaneous and induced active labor compared to women without GDM. To be able to individualize care intrapartum, there is a need for more studies demonstrating the impact of hyperglycemia during pregnancy on outcomes during childbirth.


  • Evaluation of venous plasma glucose measured by point-of-care testing (Accu-Chek Inform II) and a hospital laboratory hexokinase method (Cobas c701) in oral glucose tolerance testing during pregnancy – a challenge in diagnostic accuracy

    by Eva Landberg, Sofia Nevander, Mohammed Hadi, Marie Blomberg, Anna Norling, Bertil Ekman, Caroline Lilliecreutz

    To diagnose gestational diabetes mellitus (GDM), plasma glucose measurements during oral glucose tolerance test (OGTT) put high demands on the methods in terms of accuracy. The aim was to evaluate and compare diagnostic performance of a point-of-care test and a glucose hexokinase laboratory method. Using risk-based screening, 175 pregnant women were included. They underwent a 75 g OGTT in their 28th (median) week of gestation. Venous blood was collected in two different tubes. Plasma glucose was measured on Cobas c701 and in duplicates on AccuChek Inform II (both methods from Roche Diagnostics). Accuracy was assessed by participating in external control programs with reference method assigned values. The methods were compared for all samples (n = 512) by regression analysis; slope of 0.90 (95% CI: 0.89–0.92), intercept of 0.12 (95% CI: 0.011–0.22) and rs of 0.968. The average bias between AccuChek Inform II and Cobas c701 was −8%. The proportion of women diagnosed with GDM was 25% based on AccuChek Inform II versus 55% for Cobas c701. Results from the external control program showed a bias of approximately 5% for Cobas c701 and no significant bias for AccuChek Inform II. Cobas c701 showed a large bias both towards Accu-Chek Inform II and the reference method used in the external control program, clearly exceeding the desirable bias of <2.6%. The lack of accuracy has great implications on either over- or under-diagnosis of GDM.


  • Open Access

    Mental disorders and risk factors among pregnant women with depressive symptoms in Sweden—A case‐control study

    by Caroline Lilliecreutz, Ann Josefsson, Hussein Mohammed, Agnes Josefsson, Gunilla Sydsjö

    Introduction: Identification of pregnant women suffering from depression or other mental disorders is a challenge for antenatal caregivers. The purpose of this case‐control study was to describe mental disorders and the risk factors for mental disorders in women with depressive symptoms assessed with the Edinburgh Postnatal Depression Scale during the first trimester and to compare them with pregnant women without depressive symptoms.Material and methods: In total, 2271 women answered the Edinburgh Postnatal Depression Scale at the first antenatal visit with a midwife. An Edinburgh Postnatal Depression Scale score of 13 or higher was considered to be screen‐positive and these women were further assessed. Screen‐negative pregnant women, matched for age and parity, were chosen as controls.Results: In total, 149 (6.6%) women were found to be screen‐positive. The majority (126, 85%) had at least one mental disorder or risk factor for mental disorder, such as depression (36.0%), anxiety (14.8%), or severe fear of childbirth (20.8%). The screen‐positive women were more often smokers (16.1% vs 1.3%), unemployed (19.9% vs 1.3%), or on sick leave (25.3% vs 14.1%) during pregnancy and more often used selective serotonin reuptake inhibitor during pregnancy (14.2% vs 2.7%) compared with the screen‐negative women (P<.001). Among the screen‐negative women (n = 150) only three (2%) presented with symptoms of depression during pregnancy.Conclusions: The Edinburgh Postnatal Depression Scale seems to be a valuable screening tool to detect depressive symptoms as well as other mental disorders during early pregnancy.


  • Open Access

    Comparison of Venous and Capillary Sampling in Oral Glucose Testing for the Diagnosis of Gestational Diabetes Mellitus: A Diagnostic Accuracy Cross-Sectional Study Using Accu-Chek Inform II

    by Sofia Nevander, Eva Landberg, Marie Blomberg, Bertil Ekman, Caroline Lilliecreutz

    Gestational diabetes mellitus (GDM) is a common complication with negative impacts on mother and child. The primary aim of this study was to examine whether plasma glucose cutoffs for GDM diagnosis based on venous sampling can be replaced by cutoffs based on capillary sampling. A prospective cross-sectional study was performed at an antenatal care clinic including 175 pregnant women undergoing an oral glucose tolerance test (OGTT). Duplicate samples were collected by capillary and venous puncture while fasting and 1 h and 2 h after an OGTT. Both samples were analyzed on Accu-Chek Inform II. The cutoffs for a GDM diagnosis using capillary samples were corrected from 5.1 to 5.3 mmol/L for the fasting sample, from 10.0 to 11.1 mmol/L for the 1 h sample, and from 8.5 to 9.4 mmol/L for the 2-h sample using half of the dataset. Applying these cutoffs to the remaining dataset resulted in a sensitivity, specificity, and accuracy of 85.0%, 95.0%, and 90.3%, respectively, with a positive predictive value (PPV) of 83%, an negative predictive value (NPV) of 96%, and a positive negative likelihood ratio (LHR) of 16.4 using capillary sampling for the GDM diagnosis at fasting and 2-h after. Corrected cutoffs and capillary samples can be used for the diagnosis of GDM with maintained diagnostic accuracy using Accu-Chek Inform II.


  • Open Access

    Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women’s own preferred test method into account—A Swedish randomised controlled trial

    by Caroline Lilliecreutz, Hanna Karlsson, Anna-Clara Spetz Holm

    Cervical cancer is a highly preventable disease. To not attend an organized cervical cancer screening program increases the risk for cervical dysplasia and cervical cancer. The aim was to investigate the participation rate in three different intervention groups for non- attendees in the Swedish national program for cervical screening. The participation in the recommended follow up, and the histology found were also examined. Population-based randomized control trial. It included10,614 women that had not participated in the cervical cancer screening programme during the last six years (ages 30–49) and the last eight years (ages 50–64) were randomised 1:1:1(telephone call from a midwife (offering the choice between a visit for a pap smear or an HPV self-sampling test); an HPV self-sampling test only; or the routine procedure with a yearly invitation). In the intention to treat analysis the participation rates were 25.5% (N = 803/3146) vs 34.1% (N = 1047/3068) and 7.0% (N = 250/3538) (p<0.001) for telephone, HPV self-test and control groups respectively. In the by protocol analysis including women that answered the phone call the participation rates were 31.7% (N = 565/1784) vs 26.1% (N = 788/3002) and 7.0% (N = 250/3538) (p<0.001) for telephone, HPV self-test and control groups. The corresponding results in the by protocol analysis including women that did not answer the phone call was 19.7% (N = 565/2870) vs 26.1% (N = 788/3002) and 7.0% (N = 250/3538) (p< 0.001). The majority of the women 63,4% (1131/1784) who answered the telephone wanted to participate either by booking a visit for pap smear (38,5%) or to be sent a HPV self- sampling test (24,9%) (p<0.001). Women who chose an HPV self-test were older and gave anxiety/ fear as a reason to decline participation, and they were also less likely to participate in the follow-up if found to be HPV-positive compared to the women who chose a Pap smear. The attendance to the recommended follow-up after abnormality was in total 87%. The non-attendees had a three or eight times higher risk of having a cytology result of HSIL or suspected SCC respectively, in the index sample compared to women screened as recommended (OR 3.3 CI 95% 1.9–5.2, OR 8.6 CI 1.6–30). A total of ten SCC and one adenocarcinoma were found in the histopathology results from the non-attendee group with a study intervention, while there was only one SCC in the non-attendee group without any study intervention (p = 0.02, OR 8.1 CI 95% 1.2–350). Our study suggests, according to intention to treat analysis, that the best intervention to get as many non-attendees as possible to participate is to send an HPV self-sampling test together with an invitation letter. Almost 90% of women in the study with an abnormal index sample attended follow-up. This is high enough to indicate that interventions to increase the participation among non-attendees are meaningful. International Standard Randomised Controlled Trial Number (ISRCTN) Registration number ISRCTN78719765.